相关实验视频
Updated: Jan 6, 2026

04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
1.2K
COVID-19和狂热:一个病例与一年的随访 UP
Turk psikiyatri dergisi = Turkish journal of psychiatry
|October 10, 2025
概括
这份病例报告详细介绍了一名在严重的COVID-19肺炎期间患有躁狂症的患者,强调了该病毒对中枢神经系统和心理健康的潜在影响.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 传染性疾病 传染性疾病
背景情况:
- COVID-19 (冠状病毒疾病2019) 可能会影响中枢神经系统 (CNS).
- 中枢神经系统症状可能来自神经侵入,炎症,自身免疫,压力或治疗效应.
- COVID-19可以加剧现有的精神疾病或引发新的精神疾病.
研究的目的:
- 在患有严重COVID-19肺炎的患者中呈现新发疯病例.
- 讨论可能导致COVID-19和躁狂的病因因素.
- 描述这种精神疾病的管理和一年的随访情况.
主要方法:
- 一个52岁男性的病例报告,没有先前的精神病史.
- 在COVID-19住院期间对躁狂症状发作的详细观察.
- 审查病因因素,治疗过程和一年的随访.
主要成果:
- 该患者在因严重的COVID-19肺炎住院期间出现了躁狂症状.
- 没有注意到以前的精神病或家庭病史.
- 该案突出显示了COVID-19和双相情感障碍症状的出现之间的潜在关联.
结论:
- COVID-19可能会影响中枢神经系统,并表现为精神症状,如躁狂.
- 了解COVID-19对中枢神经系统的影响对于全面的患者护理至关重要.
- 这个案例为有关COVID-19相关神经精神疾病的文献做出了贡献.
更多相关视频
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
10.9K
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
23.3K
相关概念视频
Mania and Antimanic Drugs: Overview
522
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
522
Bipolar Disorder
584
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
584
Psychosis and Antipsychotic Drugs: Overview
770
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
770
Long-term Depression
3.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.0K
Long-term Depression
33.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.0K
Psychosis: Goals of Pharmacotherapy
434
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
434